-
1
-
-
70349836253
-
Erythropoiesis stimulatory agent-resistant anemia in dialysis patients: Review of causes and management
-
Kanbay M, Perazella MA, Kasapoglu B, Koroglu M, Covic A: Erythropoiesis stimulatory agent-resistant anemia in dialysis patients: Review of causes and management. Blood Purif 29: 1-12, 2010
-
(2010)
Blood Purif
, vol.29
, pp. 1-12
-
-
Kanbay, M.1
Perazella, M.A.2
Kasapoglu, B.3
Koroglu, M.4
Covic, A.5
-
2
-
-
77956704796
-
Trial to Reduce Cardiovascular Events with Aranesp Therapy (TREAT) Investigators: Erythropoietic response and outcomes in kidney disease and type 2 diabetes
-
Solomon SD, Uno H, Lewis EF, Eckardt KU, Lin J, Burdmann EA, de Zeeuw D, Ivanovich P, Levey AS, Parfrey P, Remuzzi G, Singh AK, Toto R, Huang F, Rossert J, McMurray JJ, Pfeffer MA; Trial to Reduce Cardiovascular Events with Aranesp Therapy (TREAT) Investigators: Erythropoietic response and outcomes in kidney disease and type 2 diabetes. NEngl J Med 363: 1146-1155, 2010
-
(2010)
NEngl J Med
, vol.363
, pp. 1146-1155
-
-
Solomon, S.D.1
Uno, H.2
Lewis, E.F.3
Eckardt, K.U.4
Lin, J.5
Burdmann, E.A.6
de Zeeuw, D.7
Ivanovich, P.8
Levey, A.S.9
Parfrey, P.10
Remuzzi, G.11
Singh, A.K.12
Toto, R.13
Huang, F.14
Rossert, J.15
McMurray, J.J.16
Pfeffer, M.A.17
-
3
-
-
49149113180
-
Greater epoetin alfa responsiveness is associated with improved survival in hemodialysis patients
-
Kilpatrick RD, Critchlow CW, Fishbane S, Besarab A, Stehman-Breen C, Krishnan M, Bradbury BD: Greater epoetin alfa responsiveness is associated with improved survival in hemodialysis patients. Clin J Am Soc Nephrol 3: 1077-1083, 2008
-
(2008)
Clin J Am Soc Nephrol
, vol.3
, pp. 1077-1083
-
-
Kilpatrick, R.D.1
Critchlow, C.W.2
Fishbane, S.3
Besarab, A.4
Stehman-Breen, C.5
Krishnan, M.6
Bradbury, B.D.7
-
4
-
-
50849110807
-
Secondary analysis of the CHOIR trial epoetin-alpha dose and achieved hemoglobin outcomes
-
Szczech LA, Barnhart HX, Inrig JK, Reddan DN, Sapp S, Califf RM, Patel UD, Singh AK: Secondary analysis of the CHOIR trial epoetin-alpha dose and achieved hemoglobin outcomes. Kidney Int 74: 791-798, 2008
-
(2008)
Kidney Int
, vol.74
, pp. 791-798
-
-
Szczech, L.A.1
Barnhart, H.X.2
Inrig, J.K.3
Reddan, D.N.4
Sapp, S.5
Califf, R.M.6
Patel, U.D.7
Singh, A.K.8
-
5
-
-
0026576801
-
Carbamylated haemoglobin in normal, diabetic and uraemic patients
-
Kwan JT, Carr EC, Barron JL, Bending MR: Carbamylated haemoglobin in normal, diabetic and uraemic patients. Ann Clin Biochem 29: 206-209, 1992
-
(1992)
Ann Clin Biochem
, vol.29
, pp. 206-209
-
-
Kwan, J.T.1
Carr, E.C.2
Barron, J.L.3
Bending, M.R.4
-
6
-
-
0031932108
-
Carbamylated hemoglobin and carbamylated plasma protein in hemodialyzed patients
-
Balion CM, Draisey TF, Thibert RJ: Carbamylated hemoglobin and carbamylated plasma protein in hemodialyzed patients. Kidney Int 53: 488-495, 1998
-
(1998)
Kidney Int
, vol.53
, pp. 488-495
-
-
Balion, C.M.1
Draisey, T.F.2
Thibert, R.J.3
-
7
-
-
0035128720
-
Carbamoylation of amino acids and proteins in uremia
-
Kraus LM, Kraus AP Jr: Carbamoylation of amino acids and proteins in uremia. Kidney Int Suppl 78: S102-S107, 2001
-
(2001)
Kidney Int Suppl
, vol.78
-
-
Kraus, L.M.1
Kraus Jr., A.P.2
-
8
-
-
80055078220
-
Carbamylation-derived products: Bioactive compounds and potential biomarkers in chronic renal failure and atherosclerosis
-
Jaisson S, Pietrement C, Gillery P: Carbamylation-derived products: Bioactive compounds and potential biomarkers in chronic renal failure and atherosclerosis. Clin Chem 57: 1499-1505, 2011
-
(2011)
Clin Chem
, vol.57
, pp. 1499-1505
-
-
Jaisson, S.1
Pietrement, C.2
Gillery, P.3
-
9
-
-
24944550971
-
Carbamylated low-density lipoprotein induces death of endothelial cells: A link to atherosclerosis in patients with kidney disease
-
Ok E, Basnakian AG, Apostolov EO, Barri YM, Shah SV: Carbamylated low-density lipoprotein induces death of endothelial cells: A link to atherosclerosis in patients with kidney disease. Kidney Int 68: 173-178, 2005
-
(2005)
Kidney Int
, vol.68
, pp. 173-178
-
-
Ok, E.1
Basnakian, A.G.2
Apostolov, E.O.3
Barri, Y.M.4
Shah, S.V.5
-
10
-
-
3042725549
-
Derivatives of erythropoietin that are tissue protective but not erythropoietic
-
LeistM, Ghezzi P, Grasso G, Bianchi R, Villa P, Fratelli M, Savino C, Bianchi M, Nielsen J, Gerwien J, Kallunki P, Larsen AK, Helboe L, Christensen S, Pedersen LO, Nielsen M, Torup L, Sager T, Sfacteria A, Erbayraktar S, Erbayraktar Z, Gokmen N, Yilmaz O, Cerami-Hand C, Xie QW, Coleman T, Cerami A, Brines M: Derivatives of erythropoietin that are tissue protective but not erythropoietic. Science 305: 239-242, 2004
-
(2004)
Science
, vol.305
, pp. 239-242
-
-
Leist, M.1
Ghezzi, P.2
Grasso, G.3
Bianchi, R.4
Villa, P.5
Fratelli, M.6
Savino, C.7
Bianchi, M.8
Nielsen, J.9
Gerwien, J.10
Kallunki, P.11
Larsen, A.K.12
Helboe, L.13
Christensen, S.14
Pedersen, L.O.15
Nielsen, M.16
Torup, L.17
Sager, T.18
Sfacteria, A.19
Erbayraktar, S.20
Erbayraktar, Z.21
Gokmen, N.22
Yilmaz, O.23
Cerami-Hand, C.24
Xie, Q.W.25
Coleman, T.26
Cerami, A.27
Brines, M.28
more..
-
11
-
-
78650185999
-
The value of failure: The discovery of TNF and its natural inhibitor erythropoietin
-
Cerami A: The value of failure: The discovery of TNF and its natural inhibitor erythropoietin. J Intern Med 269: 8-15, 2011
-
(2011)
J Intern Med
, vol.269
, pp. 8-15
-
-
Cerami, A.1
-
12
-
-
0033982372
-
Impaired biological activity of erythropoietin by cyanate carbamylation
-
Mun KC, Golper TA: Impaired biological activity of erythropoietin by cyanate carbamylation. Blood Purif 18: 13-17, 2000
-
(2000)
Blood Purif
, vol.18
, pp. 13-17
-
-
Mun, K.C.1
Golper, T.A.2
-
13
-
-
0021356158
-
The clinical information value of the glycosylated hemoglobin assay
-
Nathan DM, Singer DE, Hurxthal K, Goodson JD: The clinical information value of the glycosylated hemoglobin assay. NEngl J Med 310: 341-346, 1984
-
(1984)
NEngl J Med
, vol.310
, pp. 341-346
-
-
Nathan, D.M.1
Singer, D.E.2
Hurxthal, K.3
Goodson, J.D.4
-
14
-
-
34948834705
-
Protein carbamylation links inflammation, smoking, uremia and atherogenesis
-
Wang Z, Nicholls SJ, Rodriguez ER, Kummu O, Hörkkö S, Barnard J, Reynolds WF, Topol EJ, DiDonato JA, Hazen SL: Protein carbamylation links inflammation, smoking, uremia and atherogenesis. Nat Med 13: 1176-1184, 2007
-
(2007)
Nat Med
, vol.13
, pp. 1176-1184
-
-
Wang, Z.1
Nicholls, S.J.2
Rodriguez, E.R.3
Kummu, O.4
Hörkkö, S.5
Barnard, J.6
Reynolds, W.F.7
Topol, E.J.8
DiDonato, J.A.9
Hazen, S.L.10
-
15
-
-
84875165511
-
Carbamylation of serum albumin as a risk factor for mortality in patients with kidney failure
-
Berg AH, Drechsler C, Wenger J, Buccafusca R, Hod T, Kalim S, RammaW, Parikh SM, SteenH, FriedmanDJ, Danziger J, Wanner C, Thadhani R, Karumanchi SA: Carbamylation of serum albumin as a risk factor for mortality in patients with kidney failure. Sci Transl Med 5: 175ra29, 2013
-
(2013)
Sci Transl Med
, vol.5
-
-
Berg, A.H.1
Drechsler, C.2
Wenger, J.3
Buccafusca, R.4
Hod, T.5
Kalim, S.6
Ramma, W.7
Parikh, S.M.8
Steen, H.9
Friedman, D.J.10
Danziger, J.11
Wanner, C.12
Thadhani, R.13
Karumanchi, S.A.14
-
16
-
-
84877087172
-
Protein carbamylation predicts mortality in ESRD
-
Koeth RA, Kalantar-Zadeh K, Wang Z, Fu X, TangWH, Hazen SL: Protein carbamylation predicts mortality in ESRD. J Am Soc Nephrol 24: 853-861, 2013
-
(2013)
J Am Soc Nephrol
, vol.24
, pp. 853-861
-
-
Koeth, R.A.1
Kalantar-Zadeh, K.2
Wang, Z.3
Fu, X.4
Tang, W.H.5
Hazen, S.L.6
-
17
-
-
0028806328
-
Factors determining hemoglobin carbamylation in renal failure
-
Stim J, Shaykh M, Anwar F, Ansari A, Arruda JA, DuneaG: Factors determining hemoglobin carbamylation in renal failure. Kidney Int 48: 1605-1610, 1995
-
(1995)
Kidney Int
, vol.48
, pp. 1605-1610
-
-
Stim, J.1
Shaykh, M.2
Anwar, F.3
Ansari, A.4
Arruda, J.A.5
Dunea, G.6
-
18
-
-
49249104701
-
Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis
-
GutiérrezOM, Mannstadt M, Isakova T, Rauh-Hain JA, Tamez H, Shah A, Smith K, Lee H, Thadhani R, JüppnerH, WolfM: Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis. N Engl J Med 359: 584-592, 2008
-
(2008)
N Engl J Med
, vol.359
, pp. 584-592
-
-
Gutiérrez, O.M.1
Mannstadt, M.2
Isakova, T.3
Rauh-Hain, J.A.4
Tamez, H.5
Shah, A.6
Smith, K.7
Lee, H.8
Thadhani, R.9
Jüppner, H.10
Wolf, M.11
-
19
-
-
0042343804
-
Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy
-
Teng M, Wolf M, Lowrie E, Ofsthun N, Lazarus JM, Thadhani R: Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy. N Engl J Med 349: 446-456, 2003
-
(2003)
N Engl J Med
, vol.349
, pp. 446-456
-
-
Teng, M.1
Wolf, M.2
Lowrie, E.3
Ofsthun, N.4
Lazarus, J.M.5
Thadhani, R.6
-
21
-
-
84869143848
-
L-carnitine treatment in incident hemodialysis patients: The multicenter, randomized, doubleblinded, placebo-controlled CARNIDIAL trial
-
Mercadal L, Coudert M, Vassault A, Pieroni L, Debure A, Ouziala M, Depreneuf H, Fumeron C, Servais A, Bassilios N, Bécart J, Assogba U, Allouache M, Bouali B, Luong N, Dousseaux MP, Tezenas-du Montcel S, DerayG: L-carnitine treatment in incident hemodialysis patients: The multicenter, randomized, doubleblinded, placebo-controlled CARNIDIAL trial. Clin J Am Soc Nephrol 7: 1836-1842, 2012
-
(2012)
Clin J Am Soc Nephrol
, vol.7
, pp. 1836-1842
-
-
Mercadal, L.1
Coudert, M.2
Vassault, A.3
Pieroni, L.4
Debure, A.5
Ouziala, M.6
Depreneuf, H.7
Fumeron, C.8
Servais, A.9
Bassilios, N.10
Bécart, J.11
Assogba, U.12
Allouache, M.13
Bouali, B.14
Luong, N.15
Dousseaux, M.P.16
Tezenas-du Montcel, S.17
Deray, G.18
-
22
-
-
34547414592
-
Hemoglobin level variability: Associations with comorbidity, intercurrent events, and hospitalizations
-
Ebben JP, Gilbertson DT, Foley RN, Collins AJ: Hemoglobin level variability: Associations with comorbidity, intercurrent events, and hospitalizations. Clin J AmSoc Nephrol 1: 1205-1210, 2006
-
(2006)
Clin J AmSoc Nephrol
, vol.1
, pp. 1205-1210
-
-
Ebben, J.P.1
Gilbertson, D.T.2
Foley, R.N.3
Collins, A.J.4
-
23
-
-
72549113461
-
Haemoglobin fluctuations in patients on haemodialysis treated with ESAs: Clinical observations from two centres
-
Roche A, Macdougall IC, Walker RG: Haemoglobin fluctuations in patients on haemodialysis treated with ESAs: Clinical observations from two centres. Curr Med Res Opin 25: 2971-2976, 2009
-
(2009)
Curr Med Res Opin
, vol.25
, pp. 2971-2976
-
-
Roche, A.1
McDougall, I.C.2
Walker, R.G.3
-
25
-
-
0030024703
-
Complement C4 phenotypes in patients with end-stage renal disease
-
Lhotta K, Schlögl A, Uring-Lambert B, Kronenberg F, König P: Complement C4 phenotypes in patients with end-stage renal disease. Nephron 72: 442-446, 1996
-
(1996)
Nephron
, vol.72
, pp. 442-446
-
-
Lhotta, K.1
Schlögl, A.2
Uring-Lambert, B.3
Kronenberg, F.4
König, P.5
-
26
-
-
0018889593
-
Plasma protein carbamylation and decreased acidic drug protein binding in uremia
-
Erill S, Calvo R, Carlos R: Plasma protein carbamylation and decreased acidic drug protein binding in uremia. Clin Pharmacol Ther 27: 612-618, 1980
-
(1980)
Clin Pharmacol Ther
, vol.27
, pp. 612-618
-
-
Erill, S.1
Calvo, R.2
Carlos, R.3
-
27
-
-
0028260819
-
Decreased clearance of uraemic and mildly carbamylated low-density lipoprotein
-
Hörkkö S, Huttunen K, Kervinen K, Kesäniemi YA: Decreased clearance of uraemic and mildly carbamylated low-density lipoprotein. Eur J Clin Invest 24: 105-113, 1994
-
(1994)
Eur J Clin Invest
, vol.24
, pp. 105-113
-
-
Hörkkö, S.1
Huttunen, K.2
Kervinen, K.3
Kesäniemi, Y.A.4
-
28
-
-
0019484159
-
Hemoglobin carbamylation in uremia
-
Flückiger R, HarmonW, MeierW, Loo S, Gabbay KH:Hemoglobin carbamylation in uremia. N Engl J Med 304: 823-827, 1981
-
(1981)
N Engl J Med
, vol.304
, pp. 823-827
-
-
Flückiger, R.1
Harmon, W.2
Meier, W.3
Loo, S.4
Gabbay, K.H.5
-
29
-
-
73649088259
-
Long-term outcomes in online hemodiafiltration and high-flux hemodialysis: A comparative analysis
-
Vilar E, Fry AC, Wellsted D, Tattersall JE, Greenwood RN, Farrington K: Long-term outcomes in online hemodiafiltration and high-flux hemodialysis: A comparative analysis. Clin J Am Soc Nephrol 4: 1944-1953, 2009
-
(2009)
Clin J Am Soc Nephrol
, vol.4
, pp. 1944-1953
-
-
Vilar, E.1
Fry, A.C.2
Wellsted, D.3
Tattersall, J.E.4
Greenwood, R.N.5
Farrington, K.6
-
30
-
-
0027491558
-
The urea reduction ratio and serum albumin concentration as predictors of mortality in patients undergoing hemodialysis
-
Owen WF Jr, Lew NL, Liu Y, Lowrie EG, Lazarus JM: The urea reduction ratio and serum albumin concentration as predictors of mortality in patients undergoing hemodialysis. NEngl J Med 329: 1001-1006, 1993
-
(1993)
NEngl J Med
, vol.329
, pp. 1001-1006
-
-
Owen Jr., W.F.1
Lew, N.L.2
Liu, Y.3
Lowrie, E.G.4
Lazarus, J.M.5
-
31
-
-
0030021933
-
The intensity of hemodialysis and the response to erythropoietin in patients with end-stage renal disease
-
Ifudu O, Feldman J, Friedman EA: The intensity of hemodialysis and the response to erythropoietin in patients with end-stage renal disease. N Engl J Med 334: 420-425, 1996
-
(1996)
N Engl J Med
, vol.334
, pp. 420-425
-
-
Ifudu, O.1
Feldman, J.2
Friedman, E.A.3
-
32
-
-
0035164804
-
Adequacy of dialysis reduces the doses of recombinant erythropoietin independently from the use of biocompatible membranes in haemodialysis patients
-
Movilli E, Cancarini GC, Zani R, Camerini C, Sandrini M, Maiorca R: Adequacy of dialysis reduces the doses of recombinant erythropoietin independently from the use of biocompatible membranes in haemodialysis patients. Nephrol Dial Transplant 16: 111-114, 2001
-
(2001)
Nephrol Dial Transplant
, vol.16
, pp. 111-114
-
-
Movilli, E.1
Cancarini, G.C.2
Zani, R.3
Camerini, C.4
Sandrini, M.5
Maiorca, R.6
-
33
-
-
0030938145
-
High C-reactive protein is a strong predictor of resistance to erythropoietin in hemodialysis patients
-
Bárány P, Divino Filho JC, Bergström J: High C-reactive protein is a strong predictor of resistance to erythropoietin in hemodialysis patients. Am J Kidney Dis 29: 565-568, 1997
-
(1997)
Am J Kidney Dis
, vol.29
, pp. 565-568
-
-
Bárány, P.1
Divino Filho, J.C.2
Bergström, J.3
-
34
-
-
79961104471
-
Renal anemia of inflammation: The name is self-explanatory
-
Yilmaz MI, Solak Y, Covic A, Goldsmith D, Kanbay M: Renal anemia of inflammation: The name is self-explanatory. Blood Purif 32: 220-225, 2011
-
(2011)
Blood Purif
, vol.32
, pp. 220-225
-
-
Yilmaz, M.I.1
Solak, Y.2
Covic, A.3
Goldsmith, D.4
Kanbay, M.5
-
35
-
-
0032943841
-
Acute-phase response predicts erythropoietin resistance in hemodialysis and peritoneal dialysis patients
-
Gunnell J, Yeun JY, Depner TA, Kaysen GA: Acute-phase response predicts erythropoietin resistance in hemodialysis and peritoneal dialysis patients. Am J Kidney Dis 33: 63-72, 1999
-
(1999)
Am J Kidney Dis
, vol.33
, pp. 63-72
-
-
Gunnell, J.1
Yeun, J.Y.2
Depner, T.A.3
Kaysen, G.A.4
-
36
-
-
0141508878
-
Effect of malnutrition-inflammation complex syndrome on EPO hyporesponsiveness in maintenance hemodialysis patients
-
Kalantar-Zadeh K, McAllister CJ, Lehn RS, Lee GH, Nissenson AR, Kopple JD: Effect of malnutrition-inflammation complex syndrome on EPO hyporesponsiveness in maintenance hemodialysis patients. Am J Kidney Dis 42: 761-773, 2003
-
(2003)
Am J Kidney Dis
, vol.42
, pp. 761-773
-
-
Kalantar-Zadeh, K.1
McAllister, C.J.2
Lehn, R.S.3
Lee, G.H.4
Nissenson, A.R.5
Kopple, J.D.6
-
37
-
-
4344698082
-
Presence of a failed kidney transplant in patients who are on hemodialysis is associated with chronic inflammatory state and erythropoietin resistance
-
López-Gómez JM, Pérez-Flores I, Jofré R, Carretero D, Rodríguez-Benitez P, Villaverde M, Pérez-García R, Nassar GM, Niembro E, Ayus JC: Presence of a failed kidney transplant in patients who are on hemodialysis is associated with chronic inflammatory state and erythropoietin resistance. J Am Soc Nephrol 15: 2494-2501, 2004
-
(2004)
J Am Soc Nephrol
, vol.15
, pp. 2494-2501
-
-
López-Gómez, J.M.1
Pérez-Flores, I.2
Jofré, R.3
Carretero, D.4
Rodríguez-Benitez, P.5
Villaverde, M.6
Pérez-García, R.7
Nassar, G.M.8
Niembro, E.9
Ayus, J.C.10
-
38
-
-
29244487098
-
Challenging the validity of the EPO index
-
Kaysen GA, Müller HG, Ding J, Chertow GM: Challenging the validity of the EPO index. Am J Kidney Dis 47: 166, 2006
-
(2006)
Am J Kidney Dis
, vol.47
, pp. 166
-
-
Kaysen, G.A.1
Müller, H.G.2
Ding, J.3
Chertow, G.M.4
-
39
-
-
70349580760
-
Scavenger receptors of endothelial cells mediate the uptake and cellular proatherogenic effects of carbamylated LDL
-
Apostolov EO, Shah SV, Ray D, Basnakian AG: Scavenger receptors of endothelial cells mediate the uptake and cellular proatherogenic effects of carbamylated LDL. Arterioscler Thromb Vasc Biol 29: 1622-1630, 2009
-
(2009)
Arterioscler Thromb Vasc Biol
, vol.29
, pp. 1622-1630
-
-
Apostolov, E.O.1
Shah, S.V.2
Ray, D.3
Basnakian, A.G.4
-
40
-
-
34247223322
-
Carbamylated lowdensity lipoprotein induces monocyte adhesion to endothelial cells through intercellular adhesion molecule-1 and vascular cell adhesion molecule-1
-
Apostolov EO, Shah SV, Ok E, Basnakian AG: Carbamylated lowdensity lipoprotein induces monocyte adhesion to endothelial cells through intercellular adhesion molecule-1 and vascular cell adhesion molecule-1. Arterioscler Thromb Vasc Biol 27: 826-832, 2007
-
(2007)
Arterioscler Thromb Vasc Biol
, vol.27
, pp. 826-832
-
-
Apostolov, E.O.1
Shah, S.V.2
Ok, E.3
Basnakian, A.G.4
-
41
-
-
80052412857
-
Glycated and carbamylated albumin are more "nephrotoxic" than unmodified albumin in the amphibian kidney
-
Gross ML, Piecha G, Bierhaus A, HankeW, Henle T, Schirmacher P, Ritz E: Glycated and carbamylated albumin are more "nephrotoxic" than unmodified albumin in the amphibian kidney. Am J Physiol Renal Physiol 301: F476-F485, 2011
-
(2011)
Am J Physiol Renal Physiol
, vol.301
-
-
Gross, M.L.1
Piecha, G.2
Bierhaus, A.3
Hanke, W.4
Henle, T.5
Schirmacher, P.6
Ritz, E.7
|